// App-Quantinova.ai

: The Clinicalpathological Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis (VITT) Following ChAdOx1 (AstraZeneca AZD1222) Vaccination and Case Outcomes in Australia

Researchers

Presenter

  • Huyen Tran

Principal Investigators

  • Lucy Deng

  • Nicholas Wood

  • Vivien M Chen

Medical Centers

  • Haemostasis & Thrombosis Unit, Haemophilia Treatment Centre, The Alfred Hospital, Melbourne, Australia

  • Australian Centre For Blood Diseases, Monash University, Melbourne, Australia

  • National Centre for Immunisation Research and Surveillance, Sydney, Australia

  • ANZAC Research Institute, University of Sydney, Sydney, AUSTRALIA

Locations

  • Australia

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Autoimmune (AI)

Disease

  • Immune thrombocytopenia

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A